May 22 (Reuters) - Healthscope Ltd (HSO) : COMPLETED PREVIOUSLY...

May 22 (Reuters) - Healthscope Ltd (HSO) :

• COMPLETED PREVIOUSLY ANNOUNCED REVIEW OF ITS PORTFOLIO OF 45 HOSPITALS
• FY18 RESULTS WILL INCLUDE A NON-OPERATING CHARGE OF APPROXIMATELY $17 MILLION COMPRISING ASSET WRITE-DOWNS, REDUNDANCIES AND OTHER COSTS
• GEELONG PRIVATE, COTHAM PRIVATE AND FRANKSTON PRIVATE HOSPITALS EXPECTED TO INCUR HOSPITAL OPERATING EBITDA LOSS IN FY18 OF ABOUT $8 MILLION
• HOSPITALS OPERATING EBITDA IN SECOND HALF IS EXPECTED TO BE IN LINE WITH PRIOR CORRESPONDING PERIOD
• FY18 RESULTS WILL ALSO INCLUDE A NON-OPERATING IMPAIRMENT CHARGE OF APPROXIMATELY $68 MILLION
• HEALTHSCOPE IS TARGETING FY19 HOSPITAL OPERATING EBITDA GROWTH OF AT LEAST 10% COMPARED WITH FY18
• EXPECTS HOSPITAL OPERATING EBITDA FOR FY18 TO BE BETWEEN $340 MILLION AND $345 MILLION
• TO CLOSE GEELONG PRIVATE HOSPITAL AND COTHAM PRIVATE HOSPITAL, AND RECORD IMPAIRMENT RELATING TO FRANKSTON PRIVATE HOSPITAL
• RECEIVED NUMBER OF APPROACHES TO BUY ASIAN PATHOLOGY BUSINESS
• INITIATED A SALE PROCESS TO ASSESS VALUE THAT COULD BE GENERATED BY A DIVESTMENT OF ASIAN PATHOLOGY